Strategic Licensing Collaboration Agreement between Technip Energies and SABIC

Strategic Licensing Collaboration Agreement between Technip Energies and SABIC
Strategic Licensing Collaboration Agreement between Technip Energies and SABIC

Technip Energies (PARIS:TE) and SABIC have entered into an exclusive Licensing Collaboration Agreement (LCA) under which Technip Energies will act as the worldwide licensor of SABIC’s well-established Low-Density Polyethylene (LDPE) Clean Tubular Reactor (CTR®) technology. 

This agreement expands the long-standing cooperation between the two companies and combines SABIC’s industry-leading technology with Technip Energies’ extensive experience in Polyolefins.

Technip Energies has supported the CTR® technology since 1996, contributing to basic design, engineering, construction and start-up activities, building deep operational and execution expertise.

Stephane Mespoulhes, Senior Vice President Ethylene and Polyolefins at Technip Energies, commented: “This agreement marks a significant step forward in our long-standing partnership with SABIC and strengthens Technip Energies’ position as a key player in LDPE technology licensing. By combining SABIC’s proven CTR® technology with our deep expertise in the design, fabrication of equipment, and execution of high-pressure LDPE plants, we are uniquely positioned to accelerate the deployment of high-performance LDPE solutions worldwide. Together, we enable producers to scale efficiently, safely, and reliably, meeting growing market demand while delivering tangible value to our customers.”

About Technip Energies

Technip Energies is a global technology and engineering powerhouse. With leadership positions in LNG, hydrogen, ethylene, sustainable chemistry, and CO2 management, we are contributing to the development of critical markets such as energy, energy derivatives, decarbonization, and circularity. Our complementary business segments, Technology, Products and Services (TPS) and Project Delivery, turn innovation into scalable and industrial reality.

Through collaboration and excellence in execution, our 18,000+ employees across 35 countries are fully committed to bridging prosperity with sustainability for a world designed to last.

Technip Energies generated revenues of €7.2 billion in 2025 and is listed on Euronext Paris. The Company also has American Depositary Receipts trading over the counter.

For further information: www.ten.com

Contacts

Investor Relations
Phillip Lindsay
Vice-President Investor Relations
Tel: +44 207 585 5051
Email: Phillip Lindsay

Media Relations
Jason Hyonne
Press Relations & Social Media Manager
Tel: +33 1 47 78 22 89
Email: Jason Hyonne

Attachments

SIA Merko Mājas, part of the AS Merko Ehitus group, has commenced construction of the fourth stage of the Mežpilsēta residential project in the Mežciems area in Riga. A six-storey building with 53 apartments is set to be completed at the beginning of 2028.

The Mežpilsēta (mezpilseta.merkomajas.lv) residential building will have an A energy efficiency rating. Apartment sizes range from 39 to 77 square meters, with prices of EUR 2,800 to 3,200 per square meter.

The residential development is located in the green and fast-growing Mežpilsēta neighbourhood, right next to the forest. Each apartment will have a balcony, floor-to-ceiling windows and heated floors, creating a bright and comfortable living environment. Apartment prices include private storage rooms in the basement, with the option to purchase larger storage units if needed.

The project will feature a total of 37 outdoor parking spaces, including four spaces equipped with electric charging options. Residents will also benefit from a stroller storage room on the ground floor and shared amenities that include a spacious community lounge area with a kitchen and restroom facilities. The landscaped grounds will feature a children’s playground, table tennis and recreational areas. Residents will benefit from a secure fenced yard, with additional safety ensured through security cameras inside and outside the building as well as access control system at the building entrance, stroller storage room, and basement storage area. Additional features include a bicycle repair station and enhanced technical solutions, such as decentralised ventilation units and underfloor heating with individual room temperature control.

This will be the sixth building in the Mežpilsēta residential development. Four buildings comprising 164 apartments have already been completed, while a fifth building with 53 apartments is under construction and is scheduled to be completed by the end of 2026. The Mežpilsēta project consists in total of 11 residential buildings with 535 apartments.

SIA Merko Mājas (merkomajas.lv) is a recognised Latvian residential developer. To ensure the best quality, convenience and assurance for home buyers, Merko manages all phases of development: planning, design, construction, sales, and warranty service.

Additional information: Mr. Roberts Rēboks, Board member of SIA Merko Mājas, phone: +371 2806 1061.

Urmas Somelar
Head of Finance
AS Merko Ehitus
+372 650 1250
urmas.somelar@merko.ee

AS Merko Ehitus (group.merko.ee) group companies construct buildings and infrastructure and develop real estate. We create a better living environment and build the future. We operate in Estonia, Latvia and Lithuania. As at the end of 2025, the group employed 613 people, and the group’s revenue for 2025 was EUR 311 million.

Attachments

WISeKey, SEALSQ and Canton of Jura Sign MoU to Establish a Swiss Post-Quantum Semiconductor and Cybersecurity Center

Proposed CHF 40-60 million public-private initiative aims to establish sovereign semiconductor personalization capabilities in Switzerland and create up to 250+ direct jobs in the Canton of Jura

DELÉMONT, Switzerland – September 21, 2026 – WISeKey International Holding Ltd (SIX: WIHN; NASDAQ: WKEY), (“WISeKey” or “the Company”) a global leader in cybersecurity, digital identity and IoT, its subsidiary, SEALSQ Corp (NASDAQ: LAES) (“SEALSQ”), a global leader in secure semiconductors, PKI and post-quantum cybersecurity technologies, and The Republic and Canton of Jura, Switzerland, today announced the signing of a Memorandum of Understanding (“MoU”) to collaborate on the establishment of a Post-Quantum Semiconductor and Cybersecurity Center (the “Jura Center”) in the Canton of Jura.

The proposed Jura Center represents an indicative investment of approximately CHF 40-60 million over a period of six years. The initiative is intended to establish a strategic Swiss capability for the design, personalization, testing and secure provisioning of next-generation post-quantum semiconductor technologies.

At the heart of the project will be SEALSQ’s QS7001 Quantum Shield, a secure semiconductor designed to implement post-quantum cryptographic algorithms standardized by the U.S. National Institute of Standards and Technology, including ML-KEM and ML-DSA.

The Jura Center is expected to establish capabilities for cryptographic root-of-trust injection, secure firmware personalization, testing and certification, complemented progressively by ASIC design capabilities.

Building a Swiss Sovereign Semiconductor Capability
The initiative is designed to combine SEALSQ and WISeKey’s cybersecurity and semiconductor technologies with the Canton of Jura’s longstanding expertise in precision manufacturing, microtechnology and high-quality industrial production.

The project seeks to transfer skills deeply rooted in Jura’s watchmaking and microtechnology industries – including precision, quality control and traceability – into secure semiconductor personalization.

The project aims to establish approximately 40 direct jobs within two years, 150 by Year 5 and more than 250 by Year 8. At least 60% of these positions are expected to be filled by residents of the Canton.

A Public-Private Partnership
The Jura Center is expected to be developed as a public-private partnership, with the majority of its financing coming from WISeKey, SEALSQ, private investors and industrial partners. The Canton of Jura would act as a strategic catalyst, facilitating the establishment of the project and evaluating potential support within the applicable cantonal and federal frameworks.

The parties will also explore cooperation with HE-Arc Ingénierie for training, recruitment and applied research and with relevant Swiss technology and industrial organizations.

Building on the Quantix Model
This initiative builds upon the experience of Quantix Edge Security, the EUR 40 million semiconductor design and personalization center being developed in Murcia, Spain, by WISeKey and SEALSQ with Spanish partners.

The Spanish Government, through the Sociedad Española de Transformación Tecnológica (SETT), committed EUR 19.6 million to that public-private initiative in June 2025. The Jura Center intends to adapt the experience and methodologies developed in Murcia to Switzerland’s specific industrial and sovereignty requirements.

Strategic Opportunity for Switzerland
The Center will also evaluate opportunities associated with Swiss defense procurement and armasuisse industrial participation programs, where secure semiconductor and ASIC capabilities established on Swiss territory could potentially provide an attractive platform for industrial offset projects.

Secure semiconductors and ASICs are increasingly relevant to avionics, secure communications, sensors and other defense systems, creating an opportunity to strengthen Switzerland’s domestic technological and industrial base.

Carlos Moreira, Founder and CEO of WISeKey, said: “The quantum era is transforming cybersecurity into an issue of technological sovereignty. Switzerland must be able not only to design advanced security technologies, but also to personalize, provision and protect the cryptographic roots of trust inside semiconductors on Swiss soil. The Jura has an extraordinary industrial culture built around precision, reliability and microtechnology. Our ambition is to combine this industrial DNA with SEALSQ’s post-quantum semiconductor technology and create a new strategic capability for Switzerland. We are already applying this model in Murcia, where the initiative generated initial revenue during the second quarter of 2026. Based on this early commercial progress, believe the Jura Center can become an important European center for post-quantum semiconductor security, creating highly qualified employment, strengthening the regional technology ecosystem while reinforcing Switzerland’s technological sovereignty.”

Stéphane Theurillat, Minister of Economy of the Canton of Jura added, “This partnership marks an important milestone for Jura and sends a strong signal about our ambition to attract and develop strategic investments. The project combines digital infrastructure with Jura’s strong industrial capabilities and will contribute to further diversifying our economy. It also represents a significant opportunity to strengthen digital sovereignty while creating value and new business opportunities within our regional ecosystem. The Government of the Republic and Canton of Jura strongly welcomes this announcement and is fully committed to supporting the project. Together with the relevant authorities and services, we will work closely with the company to facilitate a fast and successful establishment in Jura and create the conditions for its long-term development.”

Next Steps
Following the MoU, the parties intend to establish a joint working group to develop the detailed business plan, select the site, structure the public-private financing model, develop academic and industrial partnerships, evaluate Swiss federal and armasuisse opportunities, and establish the regulatory and certification roadmap.

The concept envisages the Center operating through a Swiss company incorporated in the Canton of Jura, supported by an appropriate public-private governance structure.

Upon completion of this preparatory work, the Parties intend to move from the MoU to a detailed implementation framework governing the establishment, financing and operation of the Jura Center..

About SEALSQ:

SEALSQ is a leading innovator in Post-Quantum Technology hardware and software solutions. Our technology seamlessly integrates Semiconductors, PKI (Public Key Infrastructure), and Provisioning Services, with a strategic emphasis on developing state-of-the-art Quantum Resistant Cryptography and Semiconductors designed to address the urgent security challenges posed by quantum computing. As quantum computers advance, traditional cryptographic methods like RSA and Elliptic Curve Cryptography (ECC) are increasingly vulnerable.

SEALSQ is pioneering the development of Post-Quantum Semiconductors that provide robust, future-proof protection for sensitive data across a wide range of applications, including Multi-Factor Authentication tokens, Smart Energy, Medical and Healthcare Systems, Defense, IT Network Infrastructure, Automotive, and Industrial Automation and Control Systems. By embedding Post-Quantum Cryptography into our semiconductor solutions, SEALSQ ensures that organizations stay protected against quantum threats. Our products are engineered to safeguard critical systems, enhancing resilience and security across diverse industries.

For more information on our Post-Quantum Semiconductors and security solutions, please visit www.sealsq.com.

About WISeKey

WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN; Nasdaq: WKEY) is a global leader in cybersecurity, digital identity, and IoT solutions platform. It operates as a Swiss-based holding company through several operational subsidiaries, each dedicated to specific aspects of its technology portfolio. The subsidiaries include (i) SEALSQ Corp (Nasdaq: LAES), which focuses on semiconductors, PKI, and post-quantum technology products, (ii) WISeKey SA, which specializes in RoT and PKI solutions for secure authentication and identification in IoT, blockchain, and AI, (iii) WISeSat AG which focuses on space technology for secure satellite communication, specifically for IoT applications, (iv) WISe.ART Corp which focuses on trusted blockchain NFTs and operates the WISe.ART marketplace for secure NFT transactions, and (v) SEALCOIN AG which focuses on decentralized physical internet with DePIN technology and houses the development of the SEALCOIN platform.

Each subsidiary contributes to WISeKey’s mission of securing the internet while focusing on their respective areas of research and expertise. Their technologies seamlessly integrate into the comprehensive WISeKey platform. WISeKey secures digital identity ecosystems for individuals and objects using blockchain, AI, and IoT technologies. With over 1.6 billion microchips deployed across various IoT sectors, WISeKey plays a vital role in securing the Internet of Everything. Trusted by the OISTE/WISeKey cryptographic Root of Trust, WISeKey provides secure authentication and identification for IoT, blockchain, and AI applications. The WISeKey Root of Trust ensures the integrity of online transactions between objects and people. For more information on WISeKey’s strategic direction and its subsidiary companies, please visit www.wisekey.com.

Forward-Looking Statements

This communication contains forward-looking statements concerning WISeKey International Holding Ltd and/or its subsidiaries (collectively, “WISeKey,” “our” or “us”) and its businesses. Forward-looking statements can be identified by terms such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “will,” and similar expressions. These statements involve known and unknown risks, uncertainties and other factors that could cause WISeKey’s actual results, financial condition, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. These factors include: our ability to convert our pipeline into actual sales; the ability to realize WISeKey’s anticipated growth strategies and profitability; the development of post-quantum cryptography products and the potential market for such products; WISeKey’s plans for global customer base expansion; the expansion of the WISeSat project and the QSOC initiative; the timing and expected revenues from the commercial deployment of the QS7001 quantum-resistant semiconductor; the sufficiency of cash to meet liquidity needs; WISeKey’s ability to attract and retain customers; changes in economic conditions; market demand and semiconductor industry conditions; and the risks discussed in WISeKey’s filings with the SEC. WISeKey is providing this communication as of this date and does not undertake to update any forward-looking statements as a result of new information, future events or otherwise.

Statements regarding our business pipeline are based on management’s current estimates of potential revenue opportunities and do not represent backlog or contracted revenue. Pipeline conversion is subject to numerous factors including customer validation, technical integration requirements, certification timelines, and market conditions. There can be no assurance that pipeline opportunities will convert to actual sales or that such conversion will occur within anticipated timeframes.

This press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, and it does not constitute an offering prospectus within the meaning of the Swiss Financial Services Act (“FinSA”), the FinSA’s predecessor legislation or advertising within the meaning of the FinSA. Investors must rely on their own evaluation of WISeKey and its securities, including the merits and risks involved. Nothing contained herein is, or shall be relied on as, a promise or representation as to the future performance of WISeKey. Given the risks and uncertainties described herein, you should not place undue reliance on forward-looking statements as a prediction of actual results.

Press and Investor Contacts

WISeKey International Holding Ltd
Company Contact: Carlos Moreira
Chairman & CEO
Tel: +41 22 594 3000
info@wisekey.com 
WISeKey Investor Relations (US) 
The Equity Group Inc.
Lena Cati
Tel: +1 212 836-9611
lena.cati@theequitygroup.com

 

Aktsiaselts Infortar acquired its own shares on the Nasdaq Tallinn Stock Exchange during the period of 14 September – 18 September 2026 as follows:

Date Aggregated volume (pcs) Weighted average price per day (EUR)
14.09.2026 234 59,7026
15.09.2026 234 59,8256
16.09.2026 231 59,9913
17.09.2026 224 59,8366
18.09.2026 213 60,0000

Aktsiaselts Infortar is acquiring its own shares based on the stock exchange announcement published on 20 April 2026. The share buyback programme is managed by SEB Pank AS, which will buy back shares on behalf of Aktsiaselts Infortar.

Summary data (daily volume and weighted average prices) will be disclosed no later than on the seventh trading day following the transaction and be made available to the Estonian Financial Supervision and Resolution Authority, via the Nasdaq Tallinn system, and on Aktsiaselts Infortar´s investor website.

Further detailed information on the transactions is attached.

Infortar operates in seven countries, the company’s main fields of activity are maritime transport, energy and real estate. Infortar owns a 68.83% shareholding in Tallink Grupp, a 100% share in Elenger Grupp and a versatile and modern real estate portfolio of approx. 141,000 m2. In addition to the three main areas of activity, Infortar also operates in construction and mineral resources, agriculture, and other areas. A total of 107 companies belong to the Infortar group, including 3 associates and 2 subsidiaries of associates. Infortar employs 6890 people.

Additional information:

Kadri Laanvee
Investor Relations Manager
Phone: +372 5156662
e-mail: kadri.laanvee@infortar.ee
www.infortar.ee/en/investor

Attachment

Exploration Update for 2026 Brownfield Exploration Programme at Palito and Coringa Delivering High Grade Results

Serabi Gold plc (“Serabi” or the “Company”) (AIM:SRB, TSX:SBI, OTCQX:SRBIF), the Brazilian-focused gold mining and development company, is pleased to provide an update on the 2026 brownfield exploration programme at Palito Complex and Coringa Mine.

The primary objective of the 2026 brownfield drill programme is to expand the Company’s known gold resources by targeting high probability near mine mineralization at Palito Complex (“Palito”) and Coringa Mine (“Coringa”) as part of Phase II of the Company’s organic growth strategy to expand the Group mineral inventory to 1.5Moz+.

All validated results will be incorporated into updated Mineral Resource Estimates for Palito and Coringa, expected during Q1-2027.

EXPLORATION UPDATE HIGHLIGHTS

  • The Company is currently in the second year of its Phase II organic growth strategy to expand the total Group mineral inventory to +1.5Moz Au, with the programme expected to complete October 2026.
    • 2025 brownfield exploration programme increased consolidated Measured and Indicated (“M&I”) resources to 730,800 ounces of contained gold (2,485,800 tonnes @ 9.1 g/t Au) and consolidated inferred resources to 653,300 ounces (2,506,700 tonnes @ 8.1 g/t Au).
    • During H1-2026 20,831 metres of diamond drilling were completed, comprising 11,522 metres across 37 holes at Palito and 9,309 metres across 42 holes at Coringa.
  • The 2026 brownfield exploration programme totals 32,000 metres across Palito and Coringa, with six drill rigs currently operating across the two sites.
  • Recent results from the 2026 brownfield exploration programme continue to support resource growth potential including:
    • 26-SR-055 – 1.38 m @ 11.85 g/t Au, including 0.42 m @ 37.10 g/t Au (Coringa Serra South)
    • 26-SR-059 – 2.20 m @ 5.89 g/t Au, including 0.40 m @ 13.40 g/t Au, and 1.19 m @ 6.87 g/t Au, including 0.49 m @ 16.55 g/t Au (Coringa Serra South)
    • 26-ME-013 – 1.70 m @ 16.13 g/t Au, including 0.45 m @ 35.59 g/t Au (Coringa Meio)
    • 26-SR-062 – 1.00 m @ 6.85 g/t Au, including 0.25 m @ 25.80 g/t Au (Coringa Serra)
    • 26-FC-005 – 1.00m @ 10.11 g/t Au, including 0.25m @ 40.30 g/t Au (Coringa Cabaça)
    • 26-ME-006 – 1.50m @ 4.01 g/t Au (Coringa Encosta)
    • 26-MS-001 – 1.12m @ 6.12 g/t Au, including 0.43m @ 15.20 g/t Au (Palito Massa)
  • Results obtained to date have supported a number of new prospective models and reinterpretations. The exploration team is concentrating efforts on specific priority trends while ensuring continuous coverage of the main zones, enabling a more proactive stance while optimizing resource allocation, reduction of rework, and improving overall operations efficiency.
  • Reinterpretation of the G1-G3 corridor at Palito identified new structural drill targets with drilling to follow in H2-2026.
  • Updated Mineral Resource Estimates expected in Q1-2027 incorporating all validated results from the 2026 brownfield exploration programme.

Mike Hodgson, CEO of Serabi, commented:

“Phase II of our organic growth strategy continues to yield success with the drill bit in the second year of our brownfield exploration drilling programme at Palito and Coringa. Today’s published high-grade drill results demonstrate the potential to delineate a larger resource at both Palito and Coringa to support production growth. We expect to conclude the 2026 brownfield exploration programme in October 2026 with an updated mineral resource estimate for both Palito and Coringa targeted for Q1-2027, incorporating the drill results since our last update.

We look forward to continuing to unlock exploration value across our portfolio, where the 2025 brownfield exploration programme alone contributed to a significant increase in our total mineral inventory. We will continue to leverage our proven exploration, permitting expertise, along with our well established in-country relationships to execute on our strategy of creating a premier gold growth company in Brazil.”

DETAILED RESULTS AND TECHNICAL DISCUSSION

2026 Brownfield Exploration Program at Coringa Mine Update

Figure 1 – Map of Select Targets and Intercepts at Coringa Mine

Link: https://wp-serabi-2023.s3.eu-west-2.amazonaws.com/media/2026/09/Picture1.png

Source: Serabi Gold

The 2026 brownfield exploration programme at Coringa has drilled 9,309 metres to date in 42 diamond drill holes primarily focused on drilling identified targets along trend to the northwest and southeast of the currently producing Serra and Meio zones.

Year-to-date results continue to demonstrate the significant growth potential of the district, with positive results generated from multiple target areas including Serra South, Serra, Meio and satellite targets such as Cabaça and Encosta. Recent drill results continue to confirm the geological controls responsible for the Serra and Meio deposits extend beyond the currently defined resource areas.

The discovery of the Serra South zone in 2025, located approximately 500 metres southeast of the currently producing Serra zone, represents significant validation of the Company’s exploration model and demonstrates the potential for additional mineralized centres to occur along the broader, district-scale, structural corridor. Recent results include 1.38 m @ 11.85 g/t Au, including 0.42 m @ 37.10 g/t Au, in hole 26-SR-055 and 2.20 m @ 5.89 g/t Au, including 0.40 m @ 13.40 g/t Au, and a second interval of 1.19 m @ 6.87 g/t Au, including 0.49 m @ 16.55 g/t Au, in hole 26-SR-059, confirming continuity of the mineralised system along strike and at depth. Ramp development of Serra South zone commenced in Q2-2026.

Drill results from the Meio zone continue to demonstrate potential for resource growth immediately southeast and along trend of the current mining area. Hole 26-ME-013 returned 1.70 m @ 16.13 g/t Au, including 0.45 m @ 35.59 g/t Au. Together with additional positive intersections from holes 26-ME-012, 26-ME-009, 26-ME-010 and 26-ME-007, these results define a mineralized corridor extending for more than 200 metres beyond the limits of the current underground development and highlight the potential for future resource additions and mine-life extension at the Meio zone.

At Cabaça, hole 26-FC-005 intersected 1.00 m @ 10.11 g/t Au, including 0.25 m @ 40.30 g/t Au, from approximately 42 metres downhole. The shallow, high-grade intercept confirms the presence of significant gold mineralisation at this satellite target and further demonstrates the potential for additional mineralised centres outside the primary Serra and Meio zones.

At Encosta, hole 26-ME-006 intersected 1.50 m @ 4.01 g/t Au from approximately 4 metres downhole. The result provides initial confirmation of a target defined by coincident soil-geochemical and induced-polarisation anomalies and supports an open strike opportunity extending for more than 300 metres. Follow-up drilling in H2-2026 was designed to test the lateral and vertical continuity of the mineralised structure.

At Sr. Domingos, multiple priority drill targets were generated from discrete induced-polarisation anomalies within a previously untested portion of the Coringa district. The programme represents the first systematic drill evaluation of the target and is designed to determine whether the geophysical responses are associated with sulphide-bearing structures similar to those hosting gold mineralisation elsewhere at Coringa. Initial drill testing commenced during July.

At Pista, multiple drill targets have been defined along an approximately 400-metre gold-in-soil anomaly supported by historical artisanal workings, continuous quartz-vein structures and encouraging rock-chip results of up to 7.46 g/t Au. Mapping identified a brecciated quartz vein containing fresh pyrite, together with a broader vein and stockwork system developed along prospective northwest-southeast structural trends. The combination of geochemistry, mapping and surface mineralisation has allowed several priority drill sites to be defined.

Recent highlight intercepts for Coringa’s 2026 brownfield exploration programme include:

Hole_ID Target Observation From To Interval (m) Grade
(Au g/t)
Laboratory Results
26-SR-053

Serra South

  76.33 77.25 0.92 4.65 ALS Result
including 76.87 77.25 0.38 11.05 ALS Result
and 94.45 95.51 1.06 4.40 ALS Result
including 94.97 95.51 0.54 5.88 ALS Result
26-SR-055

Serra South

  197.63 199.01 1.38 11.85 ALS Result
including 197.93 198.35 0.42 37.10 ALS Result
and 202.12 203.12 1.00 14.65 ALS Result
including 202.37 202.62 0.25 57.20 ALS Result
26-SR-058 Serra South   122.55 123.50 0.95 4.48 ALS Result
26-SR-059

Serra South

  233.00 235.20 2.20 5.89 ALS Result
including 234.80 235.20 0.40 13.40 ALS Result
and 280.81 282.00 1.19 6.87 ALS Result
including 281.06 281.55 0.49 16.55 ALS Result
and 298.15 299.30 1.15 2.92 ALS Result
including 299.00 299.30 0.30 5.71 ALS Result
26-SR-062

Serra

  121.10 122.10 1.00 4.67 ALS Result
including 121.40 121.80 0.40 11.65 ALS Result
and 354.62 355.62 1.00 6.85 ALS Result
including 355.00 355.25 0.25 25.80 ALS Result
26-SR-063

Serra

  510.24 511.24 1.00 3.12 Palito Result
including 510.74 511.24 0.50 6.2 Palito Result
26-FC-005

Cabaça

  42.00 43.00 1.00 10.11 ALS Result
including 42.45 42.70 0.25 40.30 ALS Result
26-FC-007 Cabaça   34.50 34.75 0.25 3.78 ALS Result
26-ME-006 Encosta   4.42 5.92 1.50 4.01 ALS Result
26-ME-007 Meio   181.00 181.35 0.35 4.51 ALS Result
26-ME-009

Meio

  96.47 97.37 0.90 2.78 ALS Result
including 96.80 97.12 0.32 7.56 ALS Result
26-ME-010

Meio

  171.70 172.70 1.00 5.44 ALS Result
including 172.00 172.25 0.25 17.05 ALS Result
26-ME-012

Meio

  27.95 28.95 1.00 3.44 Palito Result
including 28.25 28.65 0.40 4.93 Palito Result
26-ME-013

Meio

  92.55 94.25 1.70 16.13 Palito Result
including 92.55 93.00 0.45 35.59 Palito Result
26-ME-014

Meio

  98.62 99.72 1.10 2.25 Palito Result
including 98.87 99.22 0.35 4.58 Palito Result

Source: Serabi Gold

Note: All drill results above have been sent to ALS for assay testing. ‘ALS Result’ denotes the results were assayed and test results received from ALS while ‘Palito result denotes assays drill results sent to ALS for testing but test results are not yet received and therefore represent Serabi internal assay results.

Figure 2 – Location of Meio Infrastructure with Recent Exploration Drillholes

Link: https://wp-serabi-2023.s3.eu-west-2.amazonaws.com/media/2026/09/Picture2.png
Source: Serabi Gold

2026 Brownfield Exploration Program at Palito Complex Update

Figure 3 – Map of Select Targets and Intercepts at Palito Complex

Link: https://wp-serabi-2023.s3.eu-west-2.amazonaws.com/media/2026/09/Picture3.png
Source: Serabi Gold

The 2026 brownfield exploration programme at Palito Complex has drilled 11,522 metres to date over 37 drill holes. The focus was to increase near-mine ounces, particularly at Senna, G3, Barrichello, Piauí and Massa.

Drilling at Senna continues to confirm the continuity to the northwest and southeast of the mineralized structure, with hole 26-SE-020 returning 0.82m @ 3.99 g/t Au, including 0.25m @ 11.20 g/t Au and an additional intercept of 1.24m @ 3.62 g/t Au including 0.35m @ 5.53g/t Au and 0.35m @ 6.56g/t Au.

The recently initiated drilling at Massa provided encouraging results, with hole 26-MS-001 returning 1.12m @ 6.12 g/t Au including 0.43m @ 15.20 g/t Au.

At Piauí, hole 26-PI-019 intersected a broad mineralised interval of 9.93m @ 1.06 g/t gold, including two internal higher-grade intervals of 0.25m @ 6.26g/t Au and 0.25m @ 4.95 g/t Au. Together with additional mineralised intersections from surrounding holes, the result supports the interpretation of a broader mineralised envelope containing discrete higher-grade zones. Ongoing geological modelling is evaluating the geometry and continuity of the Piauí mineralised system.

At Tatu, holes 26-TA-001 and 26-TA-003 returned narrow high-grade intersections of 0.28m @ 7.22 g/t Au and 0.25m @ 6.50 g/t Au, respectively. The results confirm the presence of high-grade gold-bearing structures at this early-stage target, although additional geological evaluation is required to establish their continuity and overall significance.

Recent highlight intercepts for Palito’s 2026 brownfield exploration programme include:

Hole_ID Target Obs From To Interval (m) Gold Grade
(Au g/t)
Laboratory Results
26-PI-019

Piauí

  79.07 89.00 9.93 1.06 ALS Result

Including  84.75 85.00 0.25 6.26
Including  85.00 85.25 0.25 4.95
26-PI-026 Piauí   123.20 123.60 0.40 3.20 ALS Result
26-TA-001 Tatu   122.22 122.50 0.28 7.22 ALS Result
26-TA-003 Tatu   57.25 57.50 0.25 6.50 ALS Result
26-SE-020

Senna

  48.22 49.04 0.82 3.99 ALS Result

Including  48.79 49.04 0.25 11.20
  52.81 53.83 1.02 3.49
  238.95 240.19 1.24 3.62
Including  239.24 239.59 0.35 5.53
Including  239.6 239.94 0.35 6.56
  250.92 251.36 0.44 3.70
26-MS-001

Massa

  68.61 68.86 0.25 5.95 ALS Result

  134.67 134.93 0.26 5.78
  144.05 145.17 1.12 6.12
Including  144.74 145.17 0.43 15.20
26-GT-009 G3   371.02 371.38 0.36 4.75 ALS Result
26-GT-010

G3

  431.09 432.10 1.01 7.41 Palito Result

Including  431.09 431.45 0.36 13.11
  483.61 485.00 1.39 6.13
Including  483.96 484.21 0.25 23.55

Source: Serabi Gold

Note: All drill results above have been sent to ALS for assay testing. ‘ALS Result’ denotes the results were assayed and test results received from ALS while ‘Palito result denotes assays drill results sent to ALS for testing but test results are not yet received and therefore represent Serabi internal assay results.

Reinterpretation of G1-G3 Corridor to be Tested in H2-2026

Through the integration of historical drilling, underground mapping and revised structural modelling, the exploration team developed a new geological framework suggesting several mineralized structures previously considered isolated potentially form a larger and more continuous mineralized system. The revised geological model incorporates structural offsets, branching vein systems and previously unrecognized dilation zones that may positively impact future exploration targeting and resource estimation. A diamond drilling programme was designed for H2-2026 to test priority targets generated from the updated interpretation.

Figure 4 – G3 Intercepts and Planned Drilling
Link: https://wp-serabi-2023.s3.eu-west-2.amazonaws.com/media/2026/09/Picture4.png

Source: Serabi Gold

Figure 5 – Reinterpreted G1-G3 Corridor

Link: https://wp-serabi-2023.s3.eu-west-2.amazonaws.com/media/2026/09/Picture5.png

Source: Serabi Gold

About Serabi Gold plc
Serabi Gold plc is a gold exploration, development and production company focused on the prolific Tapajós region in Pará State, northern Brazil. The Company has consistently produced 30,000 to 40,000 ounces per year with the Palito Complex and is planning to double production in the coming years with the ramp up of the Coringa Mine. Serabi Gold plc recently made a copper-gold porphyry discovery on its extensive exploration licence. The Company is headquartered in the United Kingdom with a secondary office in Toronto, Ontario, Canada.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018.

The person who arranged for the release of this announcement on behalf of the Company was Andrew Khov, Vice President, Head of Investor Relations & Business Development.

Enquiries

SERABI GOLD plc
Michael Hodgson        t +44 (0)20 7246 6830
Chief Executive Officer        m +44 (0)7799 473621

Andrew Khov         m +1 647 885 4874
Vice President, Head of Investor Relations &
Business Development
        e contact@serabigold.com

        www.serabigold.com

BEAUMONT CORNISH Limited
Nominated Adviser & Financial Adviser
Roland Cornish / Michael Cornish        t +44 (0)20 7628 3396

PEEL HUNT LLP
Joint UK Broker
Ross Allister / Georgia Langoulant        t +44 (0)20 7418 9000

TAMESIS PARTNERS LLP
Joint UK Broker
Charlie Bendon/ Richard Greenfield        t +44 (0)20 3882 2868

CAMARCO
Financial PR – Europe
Georgia Edmonds / Fergus Young        t +44 (0)20 3757 4980

Assay Results
Assay results reported within this release include those provided by the Company’s own on-site laboratory facilities at Palito and have not yet been independently verified. Serabi closely monitors the performance of its own facility against results from independent laboratory analysis for quality control purpose. As a matter of normal practice, the Company sends duplicate samples derived from a variety of the Company’s activities to accredited laboratory facilities for independent verification. Since mid-2019, over 10,000 exploration drill core samples have been assayed at both the Palito laboratory and certified external laboratory, in most cases the ALS laboratory in Belo Horizonte, Brazil. When comparing significant assays with grades exceeding 1 g/t gold, comparison between Palito versus external results record an average over-estimation by the Palito laboratory of 6.7% over this period. Based on the results of this work, the Company’s management are satisfied that the Company’s own facility shows sufficiently good correlation with independent laboratory facilities for exploration drill samples. The Company would expect that in the preparation of any future independent Reserve/Resource statement undertaken in compliance with a recognized standard, the independent authors of such a statement would not use Palito assay results without sufficient duplicates from an appropriately certificated laboratory.

Forward-looking statements
Certain statements in this announcement are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ‘‘believe’’, ‘‘could’’, “should” ‘‘envisage’’, ‘‘estimate’’, ‘‘intend’’, ‘‘may’’, ‘‘plan’’, ‘‘will’’ or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors’ current expectations and assumptions regarding the Company’s future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors’ current beliefs and assumptions and are based on information currently available to the Directors. Several factors could cause actual results to differ materially from the results discussed in the forward-looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward-looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements.

Qualified Persons Statement
The scientific and technical information contained within this announcement has been reviewed and approved by Michael Hodgson, a Director of the Company. Mr Hodgson is an Economic Geologist by training with over 30 years’ experience in the mining industry. He holds a BSc (Hons) Geology, University of London, a MSc Mining Geology, University of Leicester and is a Fellow of the Institute of Materials, Minerals and Mining and a Chartered Engineer of the Engineering Council of UK, recognizing him as both a Qualified Person for the purposes of Canadian National Instrument 43-101 and by the AIM Guidance Note on Mining and Oil & Gas Companies dated June 2009.

Notice
Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as nominated adviser to the Company in relation to the matters referred herein. Beaumont Cornish Limited is acting exclusively for the Company and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to clients of Beaumont Cornish Limited, or for providing advice in relation to the contents of this announcement or any matter referred to in it.

Neither the Toronto Stock Exchange, nor any other securities regulatory authority, has approved or disapproved of the contents of this news release

See www.serabigold.com for more information and follow us on X @Serabi_Gold

Attachment

Press release

Societe Generale presents an ambitious strategic roadmap supported
by disciplined execution

Paris, 21 September 2026

A new phase of disciplined, profitable and value-creating growth

  • Societe Generale presents its strategic roadmap for 2029, opening a new development phase after the successful transformation initiated in 2023.
  • With a simplified model, an improved risk profile, increased discipline in capital allocation, and a substantially improved financial performance, the Group is now entering a new stage of value creation based on four main priorities:
    • Decrease further our cost base: the Group will pursue its cost reduction efforts, continuing the structural measures successfully undertaken in recent years, by relying on traditional levers of simplification, operational efficiency and technological transformation, as well as on the gradual and responsible acceleration of the deployment of Artificial Intelligence (AI).
    • Accelerate its disciplined growth approach: the Group will pursue a disciplined growth strategy, in line with the selective approach implemented in recent years in terms of capital allocation and prioritizing the activities that create the most value.
    • Deepen the transformation of our businesses: (i) by relying on a unique setup and a more integrated approach in France, the Group intends to accelerate the development of French Retail Banking, Private Banking and Insurance, in order to better serve its customers; (ii) by strengthening its already highly profitable Global Banking and Investor Solutions businesses; and, (iii) by ensuring a disciplined development combining growth and improvement in the profitability of the International Mobility, Retail Banking and Financial Services activities.
    • Maintain best-in-class risk management: rigorous risk management will remain a cornerstone of the Group’s strategy, extending the actions taken since 2023 to control the risk/return profile of its activities.

Ambitious financial targets for 2029

  • Cost reduction of ~-2% vs. 2026 estimated (2026e), with a 2029 cost base expected to be below EUR 16.3bn
  • Average annual growth (CAGR) in Group revenues ~+3% on average between 2026e and 2029
  • Cost/income ratio below 55% in 2029
  • Cost of risk in a target range of 25 to 30bps in 2026e-2029
  • Return on tangible capital (ROTE) between 13% and 14% in 2029 and more than 15% in 2030 and beyond
  • CET1 ratio above 13%

An attractive distribution policy

  • The distribution policy is based on two components:
    • An ordinary distribution policy based on a distribution payout ratio of 50%1 of the reported net income, with:
      • A balanced distribution between a cash dividend payment and a share buy-back,
      • An interim dividend paid in the fourth quarter each year.
    • This ordinary distribution is expected to exceed EUR 13 billion2 over the 2026e-2029 period and will result in a low-to-mid teens3 average annual growth (CAGR) of the dividend per share over the period 2026e-2029.
    • A distribution of excess capital above the CET1 ratio of 13%. Should all this excess capital were to be distributed, distribution could amount up to EUR ~8 billion4 over the period 2026e-2029. Communications on the Group’s excess capital management will be made once a year during the second quarter results publication.
  • In total, the sum of these two components could exceed EUR 21 billion over the period.

Slawomir Krupa, Group Chief Executive Officer, says:

“Over the past three years, we have fundamentally transformed Societe Generale. We have simplified our model, strengthened our discipline, and demonstrated our ability to meet all our commitments.

This success, which is the result of the collective work of the entire company, creates a sense of shared pride and reinforces a sense of ongoing responsibility for our common future. Today, we are entering a new phase. Our ambition is clear: to accelerate our profitable growth and maintain rigorous risk and cost discipline. This will enable us to achieve high profitability, offer new opportunities to our teams, increase our capacity to support the growth of our clients, and offer an attractive distribution policy.

Thanks to the commitment of our teams, the quality of our franchises, and the many opportunities that are emerging, we are confident in our ability to achieve our new objectives in the interest of our clients, our shareholders and our employees.”

Meeting under the chairmanship of William Connelly on 18 September 2026, Societe Generale’s Board of Directors approved the Group’s strategic plan and financial objectives for 2029 and beyond.

The plan is based on an enhanced value creation equation, combining the pursuit of efficiency gains, selective and disciplined growth, rigorous risk management, and the continuous transformation of all the Group’s businesses.

Further reduce costs

In 2029, Societe Generale’s cost base is expected to be below EUR 16.3 billion, a decrease of approximately -2%, in absolute terms, compared to the 2026e level.

The Group aims to achieve a net cost reduction of approximately EUR -0.3 billion by 2029 (vs. 2026e), thanks to expected gross savings of approximately EUR 1.9 billion between 2026e and 2029. This will largely offset the impact of inflation, estimated at approximately
EUR 1 billion between 2026e and 2029, and expected incremental investments of approximately EUR 600 million over the same period.

The cost reduction measures for the 2026e-2029 period will be based on three main levers:

  • A decrease in procurement costs, excluding IT, for an amount of approximately
    EUR 0.4 billion;
  • A decrease in IT spending of approximately EUR -0.5 billion, bringing our IT intensity ratio to 12% by 2029, thanks to further simplifications, elimination of redundancies and obsolete solutions, and productivity gains enabled by AI;
  • An expected reduction in the number of employees through natural attrition.

Our fundamental work in terms of simplification, organization and process re-engineering will gradually be supported by controlled developments in AI. The implementation of numerous initiatives at Group level will generate between EUR 500 million and EUR 600 million in savings, including approximately EUR 350 million already identified by 2029. The signing of a strategic agreement with Anthropic marks a decisive step in our ambition to accelerate the adoption of corporate AI. This collaboration will strategically strengthen our productivity while increasing the quality of the service offered to our clients.

Accelerate disciplined growth

Between 2022 on a pro forma basis5 and 2026e, we expect the Group to generate an organic revenue growth of approximately +8%. Building on this momentum, Societe Generale intends to accelerate its growth by focusing its investments on activities offering the best risk-adjusted returns and the strongest value creation. These businesses include BoursoBank, Wealth and Savings, selected activities and geographies of our Global Banking and Investor Solutions division, as well as our activities in Eastern Europe and Ayvens. The Group thus aims to achieve an average annual revenue growth (CAGR) of approximately +3% over the 2026e-2029 period, while maintaining strict discipline in the use of capital, with an average annual organic growth (CAGR) in risk-weighted assets (RWA) of approximately +2% over the same period, which represents approximately EUR 25 billion in RWA in total.

In addition, the Group will continue to rely on strict criteria in the management of its portfolio of activities. Criteria include: contribution to the Group’s profitability; significant synergies within the Group; limited exposure to tail risks; leading positions in attractive markets; and, alignment with the Group’s ESG requirement.

The Group’s acquisition policy maintains a rigorous and disciplined approach, with strict investment criteria: a return on invested capital higher than the cost of capital; an accretive impact on earnings per share; a higher level of profitability (ROTE) than that of the Group; a strong strategic and industrial fit; and, a controlled execution risk.

With regards to its businesses, the Group’s ownership levels in its three main subsidiaries give it full control over their strategy while providing an optimal balance between value creation and capital allocation. This approach is fully in line with the disciplined management of the business portfolio and the Group’s selective acquisition policy.

Maintain a best-in-class risk management

Following the repositioning of its Global Markets activities since 2021, the Group has significantly reduced its exposure to market risks, notably with a -16% decline in market RWA in H1 26 compared to the average RWA between 2018 and 2022, while significantly increasing the level of revenues generated by Global Markets.

Moreover, with a solid track record in credit risk management, Societe Generale expects a net cost of risk of between 25 and 30 basis points over the 2026e-2029 period. The Group will maintain rigorous and disciplined risk management with a diversified geographical and business exposure. The Group is strongly focused on concentration risk with a global exposure of less than 13% to the five largest corporate sectors, as well as to the quality of its counterparties with more than 70% of its exposure geared toward investment grade clients. As a result, the Group’s cost of risk has been low at 23bps on average since 2023, well below its peers.

Deepen the transformation of our businesses

French Retail, Private Banking and Insurance aims to optimize its operational efficiency with a cost/income ratio of less than 55% in 2029, substantially improved compared to the 2026 target of a cost/income ratio below 60%.

To achieve this objective, the Group has implemented a strategy based on three levers:

  • Continue to reduce operating expenses with targeted streamlining of the number of branches and the central functions of the SG network as well as the ongoing suppression of a regional level of supervision;
  • Accelerate the growth of BoursoBank, which expects to reach more than 14 million clients at end-2029 and a profitability (RONE) of more than 45% each year between 2026 and 2029. In addition, BoursoBank has made a change in accounting standards. The client acquisition and loyalty bonuses that were previously recognized immediately as expenses will now be capitalized in accordance with IFRS 15 standard and amortized over their estimated 7-year recoverability period;
  • Take advantage of the growing needs of clients in terms of Wealth and Savings, aiming for approximately EUR 115 billion in assets under administration for BoursoBank, approximately EUR 180 billion in assets under management for Private Banking, and approximately EUR 205 billion in savings life insurance outstandings for 2029.

The Group intends to develop a more integrated approach to the French retail market for individuals. The Group will make greater use of the strengths of its unique retail banking model based on the complementarity of BoursoBank (the leading online bank in France) with the SG network (the fourth largest national player) and Societe Generale Private Banking (the second largest private banking player in France). In a rapidly changing French market, with an increasingly digitized and polarized banking offering, our ambition is to meet even better the expectations of our different types of clients by offering them more segmented value propositions adapted to their needs, while opening up new growth potential for the Group.

Individual and professional clients will therefore be supervised by the same manager, implementing a coherent and optimized vision and strategy with the aim of offering each client segment an adapted service offering and, for the Group, a production cost corresponding to the profitability of each of these segments.

Global Banking and Investor Solutions targets a cost/income ratio of less than 60% in 2029, substantially better than the 2026 target of below 65%. This target is based on an annual revenue growth (CAGR) of between +3% and +5% on average in Financing & Advisory (between 2026e and 2029) and a revenue range of between EUR 6.0 and 6.5 billion in Global Markets.

The strategic objectives of this pillar are structured around four levers:

  • Efficiency with the redesign and automation of processes and the acceleration of the use of AI;
  • Disciplined growth by continuing to invest in our leading global franchises. In Global Markets, our objective is to strengthen our presence with hedge funds and asset managers and further develop our Prime Brokerage activities. In Financing & Advisory, we aim to continue increasing origination and distribution volumes, while growing deposits in Transaction Banking. These franchises offer significant growth potential, which we intend to continue capturing;
  • Rigorous risk management through continued disciplined origination and a controlled appetite for market risk;
  • Acceleration of the diversification of our mix of activities and our geographical coverage, notably in the United States, to further improve the quality of our revenues.

Mobility, International Retail Banking and Financial Services aims for a cost/income ratio of less than 47% in 2029. In particular, Ayvens targets a cost/income ratio of approximately 49%6 in 2029 and a profitability (ROTE reported by Ayvens) of between 14% and 16% in 2029.

The division’s strategy is based on two levers:

  • Efficiency with the optimization of operational performance at the level of each franchise of the pillar, thanks in particular to digitization and AI;
  • Growth based on disciplined development in high-potential markets in Eastern Europe, as well as on a selective growth at Ayvens, combining expansion and margin protection. In consumer finance activities, the ambition is to maintain a high level of profitability while maintaining a controlled risk profile and a strict discipline in the underwriting of new loans.

Pursuing our ESG trajectory

Societe Generale is making concrete progress in its decarbonization strategy and is positioning itself for new growth opportunities.

The Group is continuing to implement its 2030 goals, with more than EUR 200 billion mobilized in favor of sustainable finance since 2024. It is making progress on its credit portfolio alignment targets while preparing for alignment ambitions by 2035.

The transformation of the Group’s energy mix financing is a concrete example of this progress. Societe Generale has significantly reduced its exposure to fossil fuels while increasing its financing for low-carbon energies, which accounted for 81% of commitments related to energy production at end-2025, compared to 43% at end-2019.

Thanks to the solid expertise it has developed, the Group is now broadening its scope of action to better meet the growing needs of its clients in the face of climate challenges. Today, it announces a new ambition to deploy EUR 1.5 billion in debt and equity, in order to further support the emerging players in the climate transition, and also the emerging leaders in climate change adaptation and nature-based solutions.

Furthermore, the Group confirms its commitment to the responsible management of the Bank’s transformations. The Group is also continuing its efforts to promote diversity, with the ambition of increasing the share of women in management bodies7 to 35% at Group level and 40% in France by 2029. In order to further strengthen employee shareholder engagement, the Group intends to continue to launch a Global Employee Share Ownership Program (GESOP) each year, in line with the alignment of employee and shareholder interests.8.

Regarding its contribution to society, the Group will increase the budget of the Societe Generale Foundation by 50%, with an extension of its geographical scope of intervention. A specific focus is placed on actions to strengthen financial education.

Finally, the Group intends to continue to respect the highest governance standards. The Board of Directors is composed of 91% independent directors and has had an independent and separated Chairman since 2015. Its composition is characterized by a high diversity of profiles, expertise and nationalities. The Board of Directors ensures the regular reinforcement of its members’ skills through training dedicated in particular to new strategic issues. In addition, it benefits from the expertise of a non-voting director dedicated to sustainability issues.

Disclaimer

This press release and the attached presentation, together with any materials made available to analysts or investors, any webcast or archived recording or transcript thereof, (together, the “Documentation”), which are or may be made available on https://investors.societegenerale.com/en, as well as any oral statements made in connection with the Capital Markets Day, including during any question-and-answer session, contain or may contain forward-looking statements relating to the targets and strategies of the Societe Generale Group.

These forward-looking statements are based on a series of assumptions, both general and specific, including regulatory assumptions, in particular the application of accounting principles and methods in accordance with IFRS (International Financial Reporting Standards) as adopted in the European Union, as well as the application of prudential regulations in force as at the date of the Documentation.

These forward-looking statements have also been developed from scenarios based on a number of economic assumptions in the context of a given competitive, regulatory, political and geopolitical environment.

Important factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements include, among others, overall trends in general economic activity and in Societe Generale’s markets in particular, regulatory, prudential, political and geopolitical changes, and the success of Societe Generale’s business, strategic, operating and financial initiatives. Actual results may also be affected by changes in regulatory capital, liquidity, resolution or supervisory requirements applicable to the Group.

The Group may be unable to anticipate all the risks, uncertainties, contingencies or other factors likely to affect its business and to appraise their potential consequences, or to evaluate the extent to which the occurrence of a risk or a combination of risks could cause actual results to differ materially from those provided in the Documentation.

Therefore, although Societe Generale believes that these statements are based on reasonable assumptions, these forward-looking statements are subject to numerous risks, uncertainties and contingencies arising, in particular, from a changing economic, financial, competitive, regulatory, political and geopolitical environment, including armed conflicts, international tensions, trade restrictions and political or fiscal instability in countries in which the Group operates. Such risks, uncertainties and contingencies may include matters of which the Group or its management are not yet aware or currently deem immaterial, and there can be no assurance that anticipated events will occur or that the objectives set out will actually be achieved.

Investors are advised to take into account the factors of uncertainty and risk likely to affect the operations of the Group when considering the information contained in such forward-looking statements and not to place undue reliance on such statements as predictions of actual results.

Any targets, objectives, ambitions, outlooks, estimates or other forward-looking financial information included in the Documentation are based on assumptions and judgments considered reasonable as at the date on which they are made. They do not constitute guarantees of future performance and remain subject to the risks, uncertainties and contingencies described in the Documentation and in Societe Generale’s Universal Registration Document, as amended.

Other than as required by applicable law, Societe Generale undertakes no obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise.

Certain financial indicators included in this Documentation constitute Alternative Performance Measures (“APMs”), referred to as alternative performance indicators in Societe Generale’s Universal Registration Document. Such APMs are not defined by IFRS and should be considered together with, and not as a substitute for, IFRS measures.

Societe Generale uses these indicators to monitor and assess the Group’s financial and operating performance and considers that they provide useful additional information for understanding such performance. Their definitions and calculation methodologies are provided in Section 2.3.6, “Definitions and methodology, alternative performance indicators”, of Societe Generale’s 2026 Universal Registration Document, as amended and, where applicable, in the methodological notes included in or published in connection with this Documentation. Reconciliations to the most directly reconcilable IFRS measures are provided where required and applicable. The principles governing the presentation of prudential ratios are set out separately in the Universal Registration Document and, where applicable, in the methodological notes included in or published in connection with this Documentation.

For a detailed description of the potential risk factors that could affect Societe Generale’s business activities, financial condition and results of operations, please refer to the “Risk Factors” section of Societe Generale’s 2026 Universal Registration Document filed with the French Autorité des Marchés Financiers (“AMF”) on 13 March 2026 under number D.26-0091, as amended, most recently by the second amendment filed with the AMF on 31 July 2026 under number D-26-0091-A02. These documents are available on Societe Generale’s website.

Sustainability-related information, including environmental, social and governance (“ESG”) and climate-related information, may be based on estimates, assumptions, judgments, evolving methodologies and data obtained from internal or third-party sources. Such methodologies and data may evolve over time, in particular as a result of regulatory developments, improvements in data availability or changes in market practices. Accordingly, such information may not be directly comparable over time, across reporting periods or with information published by other institutions. Further information on the Group’s sustainability-related disclosures and ESG risks is available in the “Sustainability Statement” and “Risk Factors” sections of Societe Generale’s Universal Registration Document, as amended.

This Documentation includes information pertaining to our markets and our competitive positions therein. Such information is based on market data and our actual revenues in those markets for the relevant periods.

We obtained this market information from various third-party sources, including publications, surveys, forecasts and market, industry or sustainability data providers, as well as from our own internal estimates.

Societe Generale has not independently verified these third-party sources and cannot guarantee their accuracy, truthfulness, precision or completeness.

In addition, our internal surveys and estimates have not been verified by independent experts or other independent sources.

Unless otherwise indicated, the financial information and figures included in this Documentation have not been audited.

Where financial information has been extracted from audited financial statements or financial statements subject to a limited review, its status is that specified in the relevant published financial statements or reports.

The sum of values contained in the tables and analyses may differ slightly from the total reported due to rounding rules.

No representation, warranty or undertaking, express or implied, is made as to the adequacy, accuracy, completeness or reasonableness of the information contained in the Documentation, except as required by applicable law. Neither Societe Generale nor its representatives may be held liable for any error, omission or inaccuracy or for any consequences arising from reliance placed on, or use of, the Documentation or any document or information referred to therein, except to the extent that such liability cannot be excluded or limited under applicable law.

Societe Generale

Societe Generale is a top-tier European Bank with around 110,000 employees serving 27 million clients in 58 countries across the world. We have been supporting the development of our economies for over 160 years, providing our corporate, institutional, and individual clients with a wide array of value-added advisory and financial solutions. Our long-lasting and trusted relationships with the clients, our cutting-edge expertise, our unique innovation, our ESG capabilities and leading franchises are part of our DNA and serve our most essential objective – to deliver sustainable value creation for all our stakeholders.

The Group runs three complementary sets of businesses, embedding ESG offerings for all its clients:
French Retail, Private Banking and Insurance, with leading retail bank SG and insurance franchise, premium private banking services, and the leading digital bank BoursoBank.
Global Banking and Investor Solutions, a top tier wholesale bank offering tailored-made solutions with distinctive global leadership in equity derivatives and structured finance.
Mobility, International Retail Banking and Financial Services, comprising well-established universal banks (in Czech Republic, Romania and several African countries), Ayvens, a global player in sustainable mobility, as well as specialized financing activities.

Committed to building together with its clients a better and sustainable future, Societe Generale aims to be a leading partner in the environmental transition and sustainability overall. The Group is included in the principal socially responsible investment indices: DJSI (Europe), FTSE4Good (Global and Europe), Bloomberg Gender-Equality Index, Refinitiv Diversity and Inclusion Index, Euronext Vigeo (Europe and Eurozone), STOXX Global ESG Leaders indexes, and the MSCI Low Carbon Leaders Index (World and Europe).

In case of doubt regarding the authenticity of this press release, please go to the end of the Group News page on societegenerale.com website where official Press Releases sent by Societe Generale can be certified using blockchain technology. A link will allow you to check the document’s legitimacy directly on the web page.

For more information, you can follow us on Twitter/X @societegenerale or visit our website societegenerale.com.


1 Based on reported Group net income, restated for non-monetary items and after deducting interest on deeply subordinated notes and perpetual subordinated notes.
2 Including the interim dividend of EUR 0.75 per share announced on 30 July 2026.
3 Based on a balanced distribution between the payment of a cash dividend and a share buy-back, and without taking into account the extraordinary distribution.
4 Including EUR 1.5bn of extraordinary distribution announced on 30 July 2026.
5 2022 pro forma revenues correspond to revenues reported in 2022, restated for mainly perimeter effects, TLTRO and UCS result.
6 Cost/income ratio excluding used car sales result and hyperinflation as per Ayvens’ new methodology, to be compared with a 53% target for 2026, restated on a like-for-like methodology basis (vs. 52% previously).
7 Top 250 positions or Group Leaders Circle is made up of the members of the Executive Committee, the Management Committee and the other Key Group Positions.

8 Subject to the approval of the General Meeting of Shareholders.

Attachment

SHANGHAI, Sept. 21, 2026 (GLOBE NEWSWIRE) — FREELANDER, the British Premium Intelligent All-Terrain Brand, will hold its Global Brand Launch at Emirates Palace Mandarin Oriental in Abu Dhabi on 29 September, marking a major milestone in the brand’s international expansion. With the United Arab Emirates (UAE) as its first international market, the event will introduce FREELANDER and its first strategic nameplate, FREELANDER 8, to international audiences as the brand enters the next phase of its global journey.

Image 1(1)

The launch event follows FREELANDER’s announcement at the 2026 Goodwood Festival of Speed, where the brand confirmed the UAE as its first international market and outlined plans for its launch in Abu Dhabi. FREELANDER has since confirmed its UAE dealer partnerships with Al Tayer Motors for Dubai and the Northern Emirates and Premier Motors for Abu Dhabi, establishing its local dealer network ahead of the Global Brand Launch. With the Middle East as the first strategic stop on its broader global roadmap, FREELANDER is establishing a foundation in the region for further expansion into international markets.

The Middle East also provides an important setting for FREELANDER to demonstrate its capabilities across diverse real-world user scenarios. In preparation for its international expansion, FREELANDER has conducted regional road testing across desert, coastal and urban environments, helping verify vehicle performance, thermal management and all-terrain reliability under demanding local conditions.

At the centre of the Global Brand Launch will be FREELANDER 8, the brand’s first strategic nameplate and a key expression of its three core product pillars: British Craftsmanship, Smart Confidence and All-Terrain Freedom. Designed for the NEV era and diverse international markets, FREELANDER 8 brings together premium design, intelligent technology and all-terrain capability to address the evolving mobility needs of Freedom Seekers.

Image 2

On 29 September, the Global Brand Launch will offer international audiences a closer look at FREELANDER’s brand vision, global strategy and the international variant of FREELANDER 8. The event will mark a new phase in the brand’s international development, as FREELANDER establishes its presence in the UAE and advances towards wider global expansion.

As FREELANDER takes its next step onto the international stage, Abu Dhabi will mark the beginning of a broader global journey — one that carries the spirit of Beyond the Legend to Freedom Seekers worldwide.

About FREELANDER

FREELANDER is a British Premium Intelligent All-Terrain brand jointly developed by Chery and Jaguar Land Rover. JLR leads the design and premium DNA, while Chery brings advanced technology and global top-tier supply chain capabilities. The brand is supported by a strong global foundation, including over 5,000 employees, five strategic hubs, and fully integrated capabilities spanning design, R&D, manufacturing, and global operations.

Vincent CHEN
freelander.international@mychery.com 
https://www.cheryinternational.com/

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/82532900-c299-4ca3-9944-087df4b3c33c
https://www.globenewswire.com/NewsRoom/AttachmentNg/c1680815-075a-4e79-a8d8-78b764260e25

  • Transformational merger reinforces Telix’s long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufacturing, underpinned by commercial excellence and the industry’s most extensive therapeutic pipeline.
  • ITM is the world’s leading supplier of therapeutic radioisotopes, with broad capabilities spanning lutetium-177 (177Lu), actinium-225 (225Ac) and terbium-161 (161Tb) production.
  • ITM is the only producer of globally scaled commercial-grade 177Lu and serves as a key supplier for both commercially available and future therapeutic radiopharmaceuticals.
  • ITM’s commercial-scale and profitable isotope production business significantly contributes to cash generation while deepening Telix’s supply chain for isotopes required for its therapeutics pipeline.
  • ITM’s complementary pipeline includes ITM-11 (177Lu-edotreotide), a novel therapeutic candidate for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), which has successfully completed Phase 3 development, potentially accelerating Telix’s entry into a validated commercial market for targeted radionuclide therapy (TRT).
  • Upfront consideration of US$1.65 billion on a cash-free/debt-free basis. After adjustments, ITM Shareholders are expected to be paid approximately US$1.25 billion in Telix Shares at US$11.841 per share, released as Nasdaq ADRs after the respective escrow periods.
  • Additional contingent consideration of up to US$700 million upon achievement of future regulatory approvals and commercial sales milestones for ITM-11.
  • The transaction is subject to Telix Shareholder approval and other customary closing conditions.

MELBOURNE, Australia and INDIANAPOLIS and MUNICH, Sept. 21, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE (“ITM”), a global leader in radioisotope production and radiopharmaceutical development.

The merger will further strengthen Telix’s leadership as a vertically integrated radiopharmaceutical company with the capabilities required to develop, manufacture and deliver innovative treatments to patients globally. The combined organization will be uniquely positioned as a radiopharmaceutical industry leader, differentiated by a world-class scaled isotope manufacturing business with a validated global distribution network, a market-leading commercial precision medicine platform and the industry’s most extensive therapeutic radiopharmaceutical pipeline.

Founded in 2004, ITM is a private company with a leading commercial scale radioisotope manufacturing and global distribution network spanning over 65 countries. ITM is a key supplier of 177Lu and – with a compound annual growth rate (CAGR) of 40% from 2021 to 2025 – delivered annual revenue of US$273 million in 20252. This commercial momentum is underpinned by increasing global demand for TRT and radioisotopes for commercially approved products and assets under clinical development. The global nuclear medicine market is forecast to reach US$41 billion by 20343.

ITM’s late-stage novel pipeline is complementary to Telix and includes ITM-11 (177Lu-edotreotide), a differentiated somatostatin receptor (SSTR)-targeted treatment for GEP-NETs. ITM-11 has completed a successful Phase 3 trial (COMPETE, NCT03049189)4 and fully enrolled a second indication expansion Phase 3 study (COMPOSE, NCT04919226) with an interim analysis expected in H1 2027. If approved, ITM-11 has the potential to accelerate Telix’s entry into the commercial therapeutic market and expand its presence in neuroendocrine tumors, a commercially validated and clinically significant market for TRT.

The combined organization is expected to generate unaudited pro forma 2026 revenue and income exceeding US$1.3 billion5, based on management estimates. ITM’s radioisotope manufacturing business is profitable and generates cash flow. Continued growth from manufacturing, cost savings and further targeted synergies and pipeline optimization are expected to support a positive EBITDA6 contribution in 20277 and onward. If approved by health regulators, the launch of ITM-11 is expected to drive further upside, with the potential to generate additional high-margin therapeutic revenue in the near term.

Telix Managing Director and Group CEO, Dr. Christian Behrenbruch, said, “This merger positions Telix at the forefront of the consolidation that is occurring as the industry matures. ITM is the leader in radioisotope production, with deep scientific expertise and a track record of value-adding innovation. We have enjoyed a close working relationship with ITM for many years and there is strong management alignment for the rationale behind this transaction. By combining our complementary strengths, we will create a company with commercial scale, world-leading supply and the most exciting theranostic drug portfolio in the sector. Importantly, this combination further expands our late-stage therapeutic pipeline with two completed Phase 3 trials and deepens radioisotope security, while bringing together the mission-critical capabilities needed to deliver radiopharmaceutical treatments to patients around the world.”

ITM Chief Executive Officer, Dr. Andrew Cavey, added, “Joining two radiopharmaceutical pioneers creates a company with unmatched breadth and depth across the value chain, supported by deep expertise and talent. Our management teams have a track record of working together and a nuanced understanding of our respective commercial strengths and customer relationships. Together, we believe Telix and ITM will be uniquely positioned to capitalize on rapidly growing global demand for radiopharmaceuticals to the benefit of both shareholders and patients.”

Deal Terms

Under the terms of the agreement and subject to Shareholder approval, Telix will acquire 100% of the shares in ITM for US$1.65 billion upfront on a cash-free/debt-free basis expected as follows:

  • US$1.25 billion will be paid to the sellers in the form of 105.8 million Telix shares (priced at the 30-day trailing VWAP as of signing of US$11.841) and released to the sellers as Nasdaq-listed ADRs at the end of their respective escrow periods;
  • US$302 million of net debt will be assumed by Telix at closing; and
  • US$96 million of management equity rollover and transaction expenses payable by the sellers8; and in each case subject to closing adjustments.

Additional contingent consideration of up to US$700 million will become payable upon the achievement of specified regulatory approvals and sales milestones for ITM-11 as set out below:

  • Up to US$250 million upon U.S. Food and Drug Administration (FDA) approval of ITM-11 across three different indications:
    • US$100 million upon FDA approval for expected first indication in G1-G2 GEP-NETs no later than December 31, 2027;
    • US$100 million upon FDA approval for G2-G3 GEP-NETs indication no later than December 31, 2030; and
    • US$50 million upon FDA approval for Lung NETs indication no later than December 31, 2031; and
  • Up to US$450 million based on ITM-11 net global sales in FY 2030 in excess of US$150 million.

All milestone consideration will be payable in cash or Shares9 at Telix’s election10. Consideration paid to ITM Shareholders at closing is subject to financial adjustments at closing, indemnity holdbacks, and escrow (lockup) restrictions on the Shares issued at closing of up to 15 months which may be waived in limited part to allow the sellers to pay their tax and transaction expense liabilities.

Upon completion of the transaction, Telix Shareholders will own approximately 76.3% and ITM Shareholders will own approximately 23.7% of Telix shares on issue. The transaction has been approved by Telix’s Board of Directors and, as of signing, Shareholders holding over 90%11 of ITM’s Shares. The transaction is expected to close by the end of FY 2026 subject to Telix Shareholder approval as required under the ASX Listing Rules, regulatory approvals, and other customary closing conditions.

Refer to the Investor Presentation lodged today with the ASX for further information on the transaction.

A Notice of Meeting will be sent to Telix Shareholders for an extraordinary general meeting expected to be held in November 2026.

Advisors

Morgan Stanley Australia Limited acted as exclusive financial advisor to Telix. Sidley Austin LLP and Herbert Smith Freehills Kramer LLP acted as legal counsel to Telix. Centerview Partners acted as exclusive financial advisor to ITM. Latham & Watkins LLP acted as legal counsel to ITM.

About ITM Isotope Technologies Munich SE

ITM, a leading radiopharmaceutical biotech company, is dedicated to providing a new generation of radiopharmaceutical therapeutics and diagnostics for hard-to-treat tumors. The company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and global supply of medical radioisotopes. With improved patient benefit as the driving principle for all it does, ITM advances a broad precision oncology pipeline, including multiple Phase 3 studies, combining the company’s high-quality radioisotopes with a range of targeting molecules. By leveraging two decades of pioneering radiopharma expertise, its respected industry position and its established global network, ITM strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life.

ITM is headquartered in Munich, Germany with two GMP manufacturing sites and a global distribution network spanning 65 countries. Through its agreement with Isogen, ITM has 15-year exclusive access to Bruce Power’s nuclear reactors in Canada for the irradiation services required to manufacture 177Lu. For further information, visit: www.itm-radiopharma.com

About Telix Pharmaceuticals Limited

Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX) is a commercial-stage global radiopharmaceutical company, advancing targeted theranostics to improve outcomes for people with cancer across the patient journey. Theranostics pairs a precision diagnostic with a targeted therapy to both diagnose and treat disease.

Telix’s commercial franchise is anchored by its precision diagnostics portfolio: Illuccix® (kit for the preparation of gallium-68 gozetotide injection), commercially available in 22 countries including the U.S., and Gozellix® (kit for the preparation of gallium-68 gozetotide injection), approved by the U.S. Food and Drug Administration (FDA) for prostate imaging, and Pixclara® (floretyrosine F 18) approved by the FDA for glioma imaging. The Company’s late-stage therapeutic pipeline includes three investigational assets in pivotal-stage trials: TLX591-Tx (lutetium-177 (177Lu) rosopatamab tetraxetan) in prostate cancer, TLX101-Tx (iodofalan 131I) in recurrent glioblastoma, and TLX250-Tx (lutetium (177Lu) girentuximab tetraxetan) in kidney cancer, additionally complemented by a deep pipeline of next generation candidates. TLX591-Tx, TLX101-Tx and TLX250-Tx have not received marketing authorizations in any jurisdiction.

Telix is headquartered in Melbourne, Australia, with operations across North America, Europe, Latin America and Asia-Pacific. For more information, visit www.telixpharma.com or follow Telix on LinkedIn, X and Facebook.

Investor Relations Media
   
Annie Kasparian
Annie.kasparian@telixpharma.com
Eliza Schleifstein
Eliza@schleifsteinpr.com
   
Charlene Jaw
Charlene.jaw@telixpharma.com
Kathleen Noonan
Kathleen.noonan@itm-radiopharma.com
   
Benedikt Orzelek
Ben.orzelek@itm-radiopharma.com
 
   

This announcement has been authorized for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board.

Legal Notices

Cautionary Statement Regarding Forward-Looking Statements.

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix and ITM disclaim any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Telix or ITM’s actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s and, as applicable, ITM’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix or ITM’s respective businesses and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix and ITM’s respective businesses, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of preclinical and clinical trials, and research and development programs; ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for product candidates, including the planned NDA resubmission for ITM-11 and the planned BLA resubmission for TLX250-Px, manufacturing activities and product marketing activities; sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of product candidates, if or when they have been approved; the parties’ ability to obtain an adequate supply of raw materials at reasonable costs for their respective products and product candidates; estimates of expenses, future revenues and capital requirements; the parties’ financial performance; developments relating to the parties’ respective competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on the parties’ respective businesses, including as a result of war or other geopolitical conflicts; and the pricing and reimbursement of the parties’ product candidates, if and after they have been approved. Telix or ITM’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of ITM or their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix, ITM or the respective owners. Trademark registration status may vary from country to country. Telix and ITM do not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

©2026 Telix Pharmaceuticals Limited and ITM Isotope Technologies Munich SE. All rights reserved.

                                  

1 Based on the 30-day trailing VWAP on the ASX prior to signing of A$16.65, converted at an AUD/USD exchange rate of 0.71.
2 ITM audited financial statements (2025).
3 MEDraysintell Current Landscape of the Nuclear Medicine Market, 2025 edition.
4 Walter T, et al. The Lancet, July 2, 2026.
5 Refer to slide 20 of the Investor Presentation released by Telix to the ASX in conjunction with this announcement.
6 Earnings before interest, tax, depreciation and amortization.
7 Subject to the realization of targeted synergies and commercial timing assumptions. Excludes one-off implementation costs.
8 Sellers may allocate and sell some of the Telix Shares deducted from closing consideration to settle a portion of these transaction expenses.
9 Priced and settled at the 30-day trailing VWAP prior to milestone achievement and converted to Nasdaq ADRs.
10 Telix will seek Shareholder approval for the issue of Shares for the milestone payments based on Telix share price at signing.
11 Remaining ITM shareholders expected to sign Joinder Agreements to the Share Purchase Agreement prior to closing.

DUBAI, United Arab Emirates, Sept. 20, 2026 (GLOBE NEWSWIRE) — FREELANDER, the British Premium Intelligent All-Terrain Brand, today announced the appointment of Al Tayer Motors and Premier Motors as its authorised distributors in the UAE, marking an important milestone in the brand’s international expansion. Lucia Mao, CEO of FREELANDER International, joined Matar Humaid Al Tayer, Vice-Chairman, Al Tayer Group, Saeed Humaid Al Tayer, Managing Director and Ashok Khanna, CEO, representing Al Tayer Motors and Premier Motors, to formalise the partnerships.

Image 1_Group Photo

Matar Humaid Al Tayer, Vice-Chairman, Al Tayer Group, Saeed Humaid Al Tayer, Managing Director and Ashok Khanna, Chief Executive Officer, Mona Hasan Sadoun, VP – Customer Experience & Marketing, representing Al Tayer Motors and Premier Motors with Lucia Mao, Chief Executive Officer, FREELANDER International and Andrew Ding, Country Director, FREELANDER, at the signing.

As FREELANDER’s first international market, the UAE will play a strategic role in the brand’s entry into the Middle East. Preparations are underway for the upcoming Global Brand Launch, officially set for 29 September in Abu Dhabi.

Al Tayer Motors has been appointed as FREELANDER’s authorised distributor across Dubai and the Northern Emirates. The brand will also be represented by Premier Motors in Abu Dhabi. With more than 40 years of experience representing top-tier automotive brands, Al Tayer Motors and Premier Motors bring established premium-segment expertise and a comprehensive sales, service and parts network to the partnership.

“FREELANDER represents an exciting addition to our portfolio. Our deep knowledge of the local market and experience in the premium automotive sector will support the brand’s growth in the UAE,” said Saeed Humaid Al Tayer, Managing Director of Al Tayer Motors and Premier Motors. “We are committed to bringing new mobility solutions to our UAE customers.”

Together, the two distributors operate a network of 32 sales and service facilities in the UAE, with capabilities spanning vehicle logistics, parts supply, warranty management, after-sales and award-winning customer service in-store and online. As part of the launch plan, three flagship showrooms have been secured in Dubai and Abu Dhabi.

Lucia Mao, CEO of FREELANDER International, commented: “These appointments mark a significant milestone in FREELANDER’s Middle East strategy. We are confident that our partnership with these two reputable distributors will give powerful impetus to the global roll-out of FREELANDER 8.”

Image 2_FREELANDER 8

As the brand’s first strategic model, FREELANDER 8 is built on the brand’s three core product pillars — British Craftsmanship, Smart Confidence and All-Terrain Freedom. Representing the next chapter of Legend Reborn, it brings premium design, intelligent technologies and all-terrain capability together for Freedom Seekers. With its UAE distribution network taking shape, FREELANDER is set to host its Global Brand Launch in Abu Dhabi on 29 September, kicking off the next phase of its international expansion.

About FREELANDER
FREELANDER is a British Premium Intelligent All-Terrain brand co-created by Chery and Jaguar Land Rover. JLR leads the design and premium DNA, while Chery brings advanced technology and global top-tier supply chain capabilities. The brand is supported by a strong global foundation, including over 5,000 employees, five strategic hubs, and fully integrated capabilities spanning design, R&D, manufacturing, and global operations.

Vincent CHEN
freelander.international@mychery.com 
https://www.cheryinternational.com/ 

Photos accompanying this announcement are available at 

https://www.globenewswire.com/NewsRoom/AttachmentNg/9882e6ec-1297-49b9-a33e-15653cc035a4

https://www.globenewswire.com/NewsRoom/AttachmentNg/2af3ed44-e3de-446f-952e-8a09f9c2f739

Not for distribution to United States newswire services or for dissemination in the United States

VANCOUVER, British Columbia, Sept. 20, 2026 (GLOBE NEWSWIRE) — Banyan Gold Corp. (TSXV:BYN) (OTCQB: BYAGF) (“Banyan” or the “Company”) announces today that it has entered into an agreement pursuant to which Canaccord Genuity Corp. has agreed to act as lead agent and sole bookrunner, for and on behalf of a syndicate of agents (the “Agents”), in connection with a best efforts private placement (the “Offering“) of up to 25,000,000 shares of the Company (each, a “Share”) at a price of $2.00 per Share, for gross proceeds of up to $50,000,000.

The Offering is expected to close on or about September 29, 2026, or such other date as the Company and the Agents may agree and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals including the conditional approval of the TSX Venture Exchange. Concurrently with the closing of the Offering, the Company also intends to issue up to 8,000,000 Shares on a non-brokered private placement basis at a price of $2.00 per Share, to raise additional gross proceeds of up to $8,000,000 (the “Concurrent Offering“).

The net proceeds from the sale of the Shares pursuant to the Offering and Concurrent Offering will be used for advancement of the Company’s Yukon projects and general corporate and working capital purposes.

Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions (“NI 45-106”), the Shares to be issued pursuant to the Offering will be offered for sale to purchasers resident in Canada and/or other qualifying jurisdictions pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 as amended and supplemented by Coordinated Blanket Order 45-935 Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. The Shares sold pursuant to the Offering will not be subject to a hold period pursuant to applicable Canadian securities laws. The Shares sold pursuant to the Concurrent Offering will be subject to a statutory hold period expiring four months and one day following the date of issuance pursuant to applicable Canadian securities laws.

There is an offering document related to the Offering that can be accessed under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Company’s website at www.banyangold.com. Prospective investors should read this offering document before making an investment decision.

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. persons unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available. “United States” and “U.S. person” have the meaning ascribed to them in Regulation S under the 1933 Act.

Upcoming Events

  • Precious Metals Summit, Beaver Creek, September 22-25, 2026
  • Corporate Presentation: September 23 at 1:30 PM MDT
  • Denver Gold Forum, Colorado Springs, September 27-30, 2026
  • The MoneyShow, Orlando, October 5-7, 2026

About Banyan

Banyan’s primary asset, the AurMac Project is located in the Traditional Territory of the First Nation of Na-Cho Nyäk Dun in Canada’s Yukon Territory. The AurMac Project comprises two main deposits, the Airstrip and Powerline Deposits.

In addition to the AurMac Project, the Company holds the Hyland Gold Project, located 70 km northeast of Watson Lake, Yukon, along the southeast end of the Tintina Gold Belt in the Traditional Territory of the Kaska Nations, closest to the Liard First Nation and Daylu Dena Council.

Banyan also holds the Nitra Gold Project and Seattle-Goodman Creek Project which are grassroots exploration projects located in the Mayo Mining district, adjacent to the AurMac Gold Project. These properties lie in the northern part of the Selwyn Basin and are underlain by metaclastic rocks of the Late Proterozoic Yusezyu Formation of the Hyland Group, similar to lithologies hosting portions of the AurMac Project. Middle Cretaceous Tombstone Plutonic suite intrusions occur along the properties including the Morrison Creek and Minto Creek stocks. The properties are 100% owned by Banyan and cover over 530 sq km. The properties are accessible by road along the Silver Trail Highway, South McQuesten Road and a network of other smaller roads across the properties.

Banyan trades on the TSX Venture Exchange under the symbol “BYN” and is quoted on the OTCQB Venture Market under the symbol “BYAGF”. For more information, please visit the corporate website at www.banyangold.com or contact the Company.

ON BEHALF OF BANYAN GOLD CORPORATION

(signed) “Tara Christie”

Tara Christie

President & CEO

For more information, please contact:

Tara Christie • 778 928 0556 • tchristie@banyangold.com 

Jasmine Sangria • 604 312 5610 • jsangria@banyangold.com 

CAUTIONARY STATEMENT: Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) nor OTCQB Venture Market accepts responsibility for the adequacy or accuracy of this release.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

FORWARD LOOKING INFORMATION: This release contains forward-looking information, which is not comprised of historical facts and is based upon the Company’s current internal expectations, estimates, projections, assumptions and beliefs. Such information can generally be identified by the use of forward-looking wording such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intend(s)”, “believe”, “potential” and “continue” or the negative thereof or similar variations. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward looking information in this news release includes, but is not limited to, the completion of the Offering and Concurrent Offering and use of proceeds to be raised pursuant thereto, the receipt of all applicable regulatory approvals, the potential for resource expansion and increased grades; mineral recoveries and anticipated mining costs. Factors that could cause actual results to differ materially from such forward-looking information include uncertainties inherent in resource estimates, continuity and extent of mineralization, capital and operating costs varying significantly from estimates, the preliminary nature of metallurgical test results, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, availability of financing, receipt of regulatory approvals, and the other risks involved in the mineral exploration and development industry, enhanced risks inherent to conducting business in any jurisdiction, and those risks set out in Banyan’s public documents filed on SEDAR+. Although Banyan believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Banyan disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.